Calidi is currently conducting IND-enabling studies for CLD-401 and anticipates submitting an Investigational New Drug (IND) application by the end of 2026. The company is also actively pursuing ...
Five-time GRAMMY®-nominated composer, performer, and multi-instrumentalist David Arkenstone returns to Arizona this holiday ...
Brightstar Lottery (formerly IGT Plc) has announced that it is close to completing its cash reward of $1bn to shareholders in ...
The trial of Kenny Alexander, ex-CEO of GVC Holdings prior to its transition to Entain, has been scheduled for early 2028.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback